Search Medical Condition
Please enter condition
Please choose location

London, India Clinical Trials

A listing of London, India clinical trials actively recruiting patients volunteers.

RESULTS

Found (375) clinical trials

Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome

The purpose of this study is to determine if two different probiotic strains, Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175, are effective in helping subjects manage the symptoms of IBS

Phase

0.08 miles

Learn More »

A Clinical Trial on the Efficacy of a Combination Herbal Product Biotropics' Nu Femme on Menopausal Symptoms and Quality of Life in Women

The purpose of this study is to assess the effectiveness of an herbal combination product called Nu Femme, on menopausal symptoms in peri-menopausal women.

Phase

0.08 miles

Learn More »

Efficacy of a LRC (L. Reuteri NCIMB 30242) Capsule on Managing Cholesterol in Adults

To investigate the effect of a supplement capsule containing LRC (L. reuteri NCIMB 30242), taken twice daily with lunch and dinner (NLT 2.5E9 CFU per dose), versus placebo capsule on serum low density lipoprotein (LDL)-cholesterol in otherwise healthy hypercholesterolemic adults after 9 weeks of product consumption.

Phase

0.08 miles

Learn More »

A Study to Evaluate OPTI-BIOME Bacillus Subtilis MB40 on Abdominal Discomfort Gas and Bloating in a Healthy Population

The purpose of this study is to investigate the effects of OPTI-BIOME (Bacillus subtilis MB40), a probiotic supplement, on bloating, gas and abdominal discomfort symptoms in otherwise healthy adults.

Phase

0.08 miles

Learn More »

A Clinical Trial to Evaluate the Effectiveness of Hairfinity on Improving Hair Health and Rate of Growth

The primary outcome of the study is the effect of Hairfinity vs. Placebo on the rate of distal hair growth, assessed using Trichoscan HD, in healthy female adults from baseline to day 90 (end of study).

Phase

0.08 miles

Learn More »

A Study Evaluating Good Idea on Glucose Homeostasis in a Healthy Population

A crossover design to evaluate the safety and efficacy of GoodIdea TM (trademark) on glucose homeostasis in a healthy population. Eligible participants will be given either the GoodIdea drink or placebo and a standardized meal and will consume both in approximately 15 minutes. Blood will be drawn at several time ...

Phase

0.08 miles

Learn More »

A Pivotal Study to Assess the InSpace Device for Treatment of Full Thickness Massive Rotator Cuff Tears

This is a non-inferiority, prospective, single blinded, multi-center, randomized, controlled, pivotal study evaluating the safety and effectiveness of the InSpace device as a primary surgical treatment for full thickness MRCT in comparison to Partial Repair of a full thickness MRCT performed during an arthroscopic procedure.

Phase N/A

0.12 miles

Learn More »

Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS

This is an event driven study to reach statistical power given all other assumptions. Subjects will visit the clinic 1 month after randomization and at regular intervals thereafter. Additionally, for any subject prematurely discontinuing study medication, assessments will be conducted every 6 months for the collection of study endpoints. Those ...

Phase

0.12 miles

Learn More »

Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)

Acute kidney injury (AKI) is a common and devastating complication of critical illness. Once AKI is established, treatment is largely supportive and no intervention has been found to restore kidney function or improve overall survival. Renal replacement therapy (RRT), usually in the form of hemodialysis, is frequently needed to manage ...

Phase

0.12 miles

Learn More »

Evaluation of Efficacy and Safety of MEDI2070 in Subjects With Active Moderate to Severe Crohn's Disease

This is a four-part Phase 2b study comprised of a 16-week, double-blind, placebo-controlled, Induction Period, a 12-week double-blind, placebo-controlled, Maintenance Period, a 24-week, Open-label Period and a post-treatment 28 week observational safety follow-up period designed to evaluate the short-term efficacy and the short- and long term safety of MEDI2070 in ...

Phase

0.12 miles

Learn More »